In Search of the Secrets of Aging
Condensed from the Government Report by the National Institute on
Aging
One hundred and twenty years, as far as we know, is the longest that
anyone has ever lived. A man in Japan, Shirechiyo Izumi, reached the age of
120 years, 237 days in 1986, according to documents that most experts think
are authentic. He died after developing pneumonia.
Long
lives always make us wonder: What is the secret? Does it lie in the genes?
Is it where people live or the way they live -- something they do or do not
do? Eat or do not eat? Most of the scientists who study aging,
gerontologists, say the secret probably lies in all of the above --
heredity, environment, and lifestyle.
But gerontologists also ask
other and more difficult questions. For example, if the 120-year-old had not
finally succumbed to illness, could he have lived on and on? Or was he
approaching some built-in, biological limit? Is there a maximum human life
span beyond which we cannot live no matter how optimal our environment or
favorable our genes?
Whether or not there is such a
limit, what happens as we age? What are the dynamics of this process and how
do they make life spans short, average, or long? Once we understand these
dynamics, could they be used to extend everyone's life span to 120 or even,
as some scientists speculate, to much greater ages?
And finally for all of us, the
most important question: How can insights into longevity be used to fight
the diseases and disabilities associated with old age to make sure this
period of life is healthy, active, and independent?
Average life span and life
expectancy in the United States have grown dramatically in this century,
from about 47 years in 1900 to about 75 years in 1990. This advance is
mostly due to improvements in sanitation, the discovery of antibiotics, and
medical care. Now, as scientists make headway against chronic diseases like
cancer and heart disease, some think it can be extended even further.
Maximum human life span seems
to be another matter. There is no evidence that it has changed for thousands
of years despite fabled fountains of youth and biblical tales of long-lived
patriarchs. However, very recently, the dream of extending life span has
shifted from legend to laboratory. As gerontologists explore the genes,
cells, and organs involved in aging, they are uncovering more and more of
the secrets of longevity. As a result, life extension may now be more than
the stuff of myth and the retardation of disease and disability, realistic
goals.
CLICK HERE TO ORDER GHR15
Hormones
In 1989, at Veterans
Administration hospitals in Milwaukee and Chicago, a small group of men aged
60 and over began receiving injections three times a week that dramatically
reversed some signs of aging. The injections increased their lean body (and
presumably muscle) mass, reduced excess fat, and thickened skin. When the
injections stopped, the men's new strength ebbed and signs of aging
returned.
What the men were taking was
recombinant human growth hormone (GH), a synthetic version of the hormone
that is produced in the pituitary gland and plays a critical part in normal
childhood growth and development. Now researchers are learning that GH, or
the decline of GH, seems also to play a role in the aging process in at
least some individuals.
The idea that hormones are
linked to aging is not new. We have long known that some hormones decline
with age. Human growth hormone levels decrease in about half of all adults
with the passage of time. Production of the sex hormones estrogen and
testosterone tends to fall off. Hormones with less familiar names, like
melatonin and thymosin, are also not as abundant in older as in younger
adults.
CLICK HERE TO ORDER GHR15
Frontiers
New territory, unexplored or
only sketchily mapped, lies ahead. As gerontologists isolate and
characterize more and more longevity- and aging-related genes in laboratory
animals, insights into genes and gene products important in human aging will
emerge. Comparable human genes will be identified and mapped to chromosomes.
This information will be useful
in designing both genetic and non-genetic interventions to slow or even
reverse some aging-related changes. Already, for example, a study by Helen
Blau of Stanford University has shown that muscle cells can be genetically
modified and injected into muscle where they will produce and secrete human
growth hormone. Non-genetic strategies will include the development of
interventions to reduce damage to cellular components, such as proteins,
nucleic acids, and lipids.
Normal aging will be more
closely defined. For instance, at NIA's Gerontology Research Center, the
behavior of the cells that line blood vessels during aging is now providing
clues to the stiffening of blood vessels that occurs with age as well as
insights into vascular disease. As key biomarkers of aging are identified,
researchers will be able to use them to test interventions to slow aging.
Studies will begin to delve more deeply into differences in aging between
the sexes and among ethnic groups.
In short, gerontologists will
be charting the paths and intersections of genetic, biochemical, and
physiologic aging. What they find will reveal some of the secrets of aging.
It may lead to extended life spans. It will very certainly contribute to
better health, less disability, and more independence in the second fifty
years of life.
CLICK HERE TO ORDER GHR15